(January 3, 2018, 11:56 AM EST) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 15 said it will hear arguments Jan. 25 on the centralization of 42 federal lawsuits alleging heart failure from the diabetes drug Onglyza (In Re: Onglyza [Saxagliptin] Products Liability Litigation, MDL Docket No. 2809, JPMDL)....